Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Financing Cash Flow

CHINA BCT PHARMACY GROUP, INC. Financing Cash Flow

CHINA BCT PHARMACY GROUP, INC. reported Financing Cash Flow of -$209.02 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was -$209.02K.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was $4.54M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $1.36M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $412.19K.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for fiscal 2012 was $5.93M, a 73.23% decline from fiscal 2011.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for fiscal 2011 was $22.16M.
  • CHINA BCT PHARMACY GROUP, INC. net cash provided by (used in) financing activities for fiscal 2010 was -$527.52K.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2013-03-31-$209.02K
10-Q · filed 2013-05-20
$4.33M
derived: sum of 2 quarters · filed 2013-05-20
$5.69M
derived: sum of 3 quarters · filed 2013-05-20
$6.10M
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31$4.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$5.89M
derived: sum of 2 quarters · filed 2013-04-15
$6.31M
derived: sum of 3 quarters · filed 2013-04-15
$5.93M
10-K · filed 2013-04-15
2012-09-30$1.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$1.77M
derived: sum of 2 quarters · filed 2012-11-15
$1.39M
10-Q · filed 2012-11-15
$669.86K
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30$412.19K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$36.03K
10-Q · filed 2012-08-17
-$686.44K
derived: sum of 3 quarters · filed 2013-05-20
-$1.20M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31-$376.16K
10-Q · filed 2013-05-20
$336.16K
10-Q · filed 2012-05-21
-$1.10M
derived: sum of 2 quarters · filed 2013-05-20
-$1.61M
derived: sum of 3 quarters · filed 2013-05-20
-$3.20M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31-$722.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$1.23M
derived: sum of 2 quarters · filed 2013-04-15
-$2.82M
derived: sum of 3 quarters · filed 2013-04-15
$22.16M
10-K · filed 2013-04-15
$22.81M
10-K · filed 2012-03-30
2011-09-30-$511.79K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
-$2.10M
derived: sum of 2 quarters · filed 2012-11-15
$22.88M
10-Q · filed 2012-11-15
$23.50M
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30-$1.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$23.39M
10-Q · filed 2012-08-17
$24.01M
derived: sum of 3 quarters · filed 2012-08-17
$22.01M
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31$24.98M
10-Q · filed 2012-05-21
$25.60M
derived: sum of 2 quarters · filed 2012-06-12
$23.60M
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31$616.79K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
-$1.39M
derived: sum of 2 quarters · filed 2012-06-12
-$527.52K
10-K/A · filed 2012-06-12
2010-09-30-$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$1.14M
10-Q · filed 2011-11-14
2010-06-30$857.81K
10-Q · filed 2011-08-15